Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
N/A
-10,289 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
N/A
-22,680 Reduced 68.79%
10,289 $139,000
Q1 2020

May 15, 2020

SELL
N/A
-32,676 Reduced 49.78%
32,969 $391,000
Q4 2019

Feb 14, 2020

BUY
N/A
40,257 Added 158.57%
65,645 $1.64 Million
Q3 2019

Nov 14, 2019

BUY
N/A
25,388 New
25,388 $432,000
Q2 2019

Aug 14, 2019

SELL
N/A
-37,365 Closed
0 $0
Q1 2019

May 15, 2019

BUY
N/A
7,581 Added 25.45%
37,365 $1.2 Million
Q4 2018

Feb 14, 2019

BUY
N/A
10,473 Added 54.23%
29,784 $839,000
Q3 2018

Nov 14, 2018

SELL
N/A
-5,753 Reduced 22.95%
19,311 $555,000
Q2 2018

Aug 14, 2018

BUY
N/A
2,423 Added 10.7%
25,064 $939,000
Q1 2018

May 15, 2018

BUY
N/A
562 Added 2.55%
22,641 $890,000
Q4 2017

Feb 14, 2018

BUY
N/A
6,640 Added 43.01%
22,079 $715,000
Q3 2017

Nov 14, 2017

BUY
N/A
15,439
15,439 $481,000

About Intersect ENT, Inc.


  • Ticker XENT
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 33,461,700
  • Market Cap $945M
More about XENT
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.